Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ICOS Corporation -- Ignore unavailable to you. Want to Upgrade?

To: SemiBull who wrote (1002)	8/28/2003 8:21:32 PM
From: SemiBull	Read Replies (1) \| Respond to of 1139

Cialis impotence drug gets approval in Mexico Thursday August 28, 9:27 am ET NEW YORK, Aug 28 (Reuters) - The impotence drug Cialis, which is awaiting regulatory approval in the United States, has been approved for sale in Mexico, the drug's makers said on Thursday. Cialis, which will compete with Pfizer Inc.'s (NYSE:PFE - News) Viagra and GlaxoSmithKline Plc's (London:GSK.L - News) Levitra, is expected to win U.S. approval late this year. Cialis is the product of a joint venture between Eli Lilly & Co. (NYSE:LLY - News) and Icos Corp. (NasdaqNM:ICOS - News). The drug has now been approved in 40 countries. The companies said Mexico is one of the top 10 world markets for erectile dysfunction therapies.